Clopidogrel plus aspirin good for noncarriers of CYP2C19 variants

June 29, 2016

(HealthDay)—For patients with minor ischemic stroke or transient ischemic attack, the risk of new stroke is reduced with use of clopidogrel plus aspirin versus aspirin alone among those who are not carriers of the CYP2C19 loss-of-function alleles, according to a study published online June 23 in the Journal of the American Medical Association. The research was published to coincide with the Second Annual Scientific Session of the Chinese Stroke Association and the Tiantan International Stroke Conference, held from June 24 to 26 in Beijing.

Yilong Wang, M.D., Ph.D., from the Capital Medical University in Beijing, and colleagues examined the correlation between CYP2C19 gene variants and clinical outcomes of clopidogrel-treated . A total of 2,933 patients with acute minor ischemic or transient ischemic attack were randomized to clopidogrel combined with or aspirin alone. Participants underwent genotyping for three CYP2C19 major alleles.

The researchers found that 41.2 percent of patients were noncarriers and 58.8 percent were carriers of loss-of-function mutations (CYP2C19*2 and *3). Noncarriers, but not carriers, of the loss-of-function alleles had a reduced rate of new stroke with clopidogrel-aspirin after 90-day follow-up (P = 0.02 for interaction). Similar results were seen for the secondary composite efficacy outcome of new composite vascular events. There was no variation for carriers versus noncarriers in the effect of treatment assignment on bleeding (P = 0.78 for interaction).

"These findings support a role of CYP2C19 genotype in the efficacy of this treatment," the authors write.

One author disclosed financial ties to Sanofi and AstraZeneca.

Explore further: Adding clopidogrel to aspirin therapy reduces risk of second stroke

More information: Abstract
Full Text
More Information

Related Stories

Adding clopidogrel to aspirin therapy reduces risk of second stroke

February 11, 2013
Adding a second drug to aspirin therapy reduced the risk of a second stroke in the weeks after Chinese patients had a minor ischemic (due to a clot) stroke or a transient ischemic attack (TIA), according to research presented ...

Increasing dosage of clopidogrel for patients with genetic variation improves response to medication

November 16, 2011
Among patients with stable cardiovascular disease who have a genetic variation that diminishes the response to the antiplatelet drug clopidogrel, tripling the standard daily dosage of this medication resulted in improved ...

Study points to challenges, hopes of helping vulnerable patients avoid stroke

May 10, 2016
A new study published in the New England Journal of Medicine today demonstrates both the importance and the challenge of treating people who are at high risk of a stroke.

Global platelet reactivity and high risk ACS patients

August 28, 2012
Global platelet reactivity is more effective than responsiveness to clopidogrel in identifying acute coronary syndrome (ACS) patients at high risk of ischemic events, according to research presented at ESC Congress 2012.

Recommended for you

Aspirin could play valuable role as additional treatment for cancer

September 26, 2018
Regular use of aspirin could help in the treatment of some cancers, finds a new review of 71 medical studies.

Height may be risk factor for varicose veins, study finds

September 24, 2018
The taller you are, the more likely you are to develop varicose veins, according to a study led by Stanford University School of Medicine researchers that examined the genes of more than 400,000 people in search of clues ...

Physical activity necessary to maintain heart-healthy lifestyle

September 24, 2018
Exercise and physical activity are of vast global importance to prevent and control the increasing problem of heart disease and stroke, according to a review paper published today in the Journal of the American College of ...

Prosthetic valve mismatches common in transcatheter valve replacement, ups risk of death

September 24, 2018
In the largest multi-institutional study to date, led by researchers from Penn Medicine, the team found that among patients who underwent a transcatheter aortic valve replacement (TAVR), a high number experienced severe and ...

Study reveals a promising alternative to corticosteroids in acute renal failure treatment

September 21, 2018
A protein produced by the human body appears to be a promising new drug candidate to treat conditions that lead to acute renal failure. This is shown by a study conducted at São Paulo State University (UNESP) in São José ...

Can a common heart condition cause sudden death?

September 20, 2018
About one person out of 500 has a heart condition known as hypertrophic cardiomyopathy (HCM). This condition causes thickening of the heart muscle and results in defects in the heart's electrical system. Under conditions ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.